Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human
Abstract
Share and Cite
Bibi, D.; Bilgraer, R.; Steiner, L.; Hallak, H. Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human. Pharmaceutics 2024, 16, 896. https://doi.org/10.3390/pharmaceutics16070896
Bibi D, Bilgraer R, Steiner L, Hallak H. Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human. Pharmaceutics. 2024; 16(7):896. https://doi.org/10.3390/pharmaceutics16070896
Chicago/Turabian StyleBibi, David, Raphael Bilgraer, Lilach Steiner, and Hussein Hallak. 2024. "Physiologically-Based Pharmacokinetic Modeling and In Vitro–In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human" Pharmaceutics 16, no. 7: 896. https://doi.org/10.3390/pharmaceutics16070896